Drug Administered Cancer Model Under One Term Delay
-
2185
Downloads
-
3262
Views
Authors
Aditya Ghosh
- Department of Mathematics, Royal Group of Institutions, Betkuchi, Guwahati, Assam-781035, INDIA
Anuradha Devi
- Department of Mathematics, Royal Group of Institutions, Betkuchi, Guwahati, Assam-781035, INDIA
Abstract
A mathematical model is presented here that describes the growth of tumor cells and intrinsic behavior of it in the presence of immune cells. In this model we have also considered another drug variable which has the effect on both the cells. Hence it is a model for cancer that contains immune, tumor and drug. The model is highly nonlinear in nature. The effect of growth of normal cell is not considered. Constant number of immune cells is assumed to be present in the system. In this model we have considered a delay term in the growth of tumor which makes the model more realistic. We also assume that drug kills both immune cells and tumor cells simultaneously in different rate. Stability of both immune and tumor cells with and without delay has been analyzed under equilibrium condition analytically as well as numerically. It is found that the stability of the model depends on both tumor cells as well as on the delay.
Share and Cite
ISRP Style
Aditya Ghosh, Anuradha Devi, Drug Administered Cancer Model Under One Term Delay, Journal of Mathematics and Computer Science, 14 (2015), no. 2, 143-150
AMA Style
Ghosh Aditya, Devi Anuradha, Drug Administered Cancer Model Under One Term Delay. J Math Comput SCI-JM. (2015); 14(2):143-150
Chicago/Turabian Style
Ghosh, Aditya, Devi, Anuradha. "Drug Administered Cancer Model Under One Term Delay." Journal of Mathematics and Computer Science, 14, no. 2 (2015): 143-150
Keywords
- Mathematical model
- Tumor cell
- Immune cell
- Drug
- Stability
- Delay
MSC
References
-
[1]
J. A. Adam , The dynamics growth-factor-modified immune response to cancer growth:One- dimensional models, Mathematical andComputer modelling , 17 (1993), 83-106.
-
[2]
J. A. Adam , J. Panetta, A simple mathematical model and alternative paradigmfor certain chemotherapeutic regimens, Mathematical and Computer modelling , 22 (8) (1995), 49-60.
-
[3]
A. Devi, A. Ghosh, Effect of Delay in Immune-Tumor Model under Drug Administration, International Journal Mathematics Research, 6(1) (2014), 99-107.
-
[4]
A. Devi, A. Ghosh, On the stability of Innume-Tumor (𝐼−𝑇)model with the effect of drug administration, International Journal of Pure and Applied Mathematics79 (4) , (2012)
-
[5]
A. Devi, A. Ghosh, On the stability of Immune-Tumor model with one term delay in Tumor\((𝐼−𝑇_𝐷)\), , 5 (2013), 1-5.
-
[6]
M. Eisen, Mathematical models in cellbiology and cancer chemotherapy, Springer-Verlag, Berlin (1979)
-
[7]
D. Kirschner, J. Panetta, Modelling immunotherapy of the tumor immune interaction, Journal of Mathematical biology, 37(3) (1998), 235-252.
-
[8]
H. Knolle, Cell kinetic modelling and the chemotherapy of Cancer, Springer-Verlag, Berlin (1988)
-
[9]
M. Soltani, A. Dadkhah , Mathematical modeling of PEM Fuel cell power module and Ultra-Capacitor for Vehicular Power System, Journal of Mathematics and Computer Science , 9 (2014), 408-425.
-
[10]
R. B. Martin, M. E. Fisher, R. F. Minchin, K. L. Teo, A mathematical model of cancer cheotherapy with an optimal selection of parameters, Mathematical Biosciences, An international Journal , 99 (2) (1990), 205-230.
-
[11]
J. M. Murrey, Optimal control for a cancer chemotherapy problem with general growth and loss functions, Mathematical Biosciences, An international Journal, 98 (2) (1990), 273-287.
-
[12]
M. Owen, J. Sherratt, Modelling the macrophase invasion of tumors: Effects on growth and composition, IMA Journal of Mathematics Applied in Medicine and Biology, 15 (1998), 165-185.
-
[13]
R. Prehn, Stimulatory effects of immune-reactions upon the growths of untranslated tumors, Cancer Research , 54(4) (1994), 908- 914.
-
[14]
E. Shochat, D. Hart, Z. Agur, Using computer simulations for evaluating the efficacy of breast cancer chemotherapy protocols, Mathematical Models and Methods in Applied Sciences , 9(4) (1999), 599-615.
-
[15]
A. J. Coldman, J. H. Goldie, A stochastic model for the origin and treatments of tumor containing drug-resistant cells, Bulletin of Mathematical Biology , Simulation in Cancer research (Durham, N. C., 1986)., 48(3-4) (1989), 279-292.
-
[16]
G. W. Swan, Optimal control applications in the chemotherapy of multiple myeloma, IMA Journal of Mathematics Applied in Medicine and Biology, 2(3) (1985), 139-160.
-
[17]
G. W. Swan, Optimal control analysis of cancer chemotherapy problem, IMA Journal of Mathematics Applied in Medicine and Biology, 4(2) (1987), 171-184.
-
[18]
L. G. De Pillis, A. Radunskaya, A Mathematical Tumor Model with Immune Resistance and Drug Therapy: an optimal Control approach, Journal of Theoretical Medicine, 3 (2000), 79-100.
-
[19]
J. N. Kapoor , Mathematical Modelling, New Age International Publishers , ISBN: 81-224-0006-x (1998)
-
[20]
M. Bodnar , The nonnegetivity of solutions of delay differential equations, Appl. Math. Let., 13(6) (2000), 91-95.
-
[21]
U. Forys , On the Mikhailovcriterian and stability of delay differential equations, Prep. Warsaw University, No. RW 01- 14(97). (2001)
-
[22]
K. Gopalsamy , Stability and Ossilations inDelay Differential Equations of Population Dynamics, , (1992)
-
[23]
J. Hale , Theory of Functional Differential Equations, Springer, New York ()
-
[24]
J. D. Murray , Mathematical Biology, Springer, Berlin ()